Patients at high risk of adverse events from intravenous contrast media after computed tomography examination

European Journal of Radiology

Volumn 62, Issue SUPPL., 2007, Pages 26-32

  Reddan, Donal ^a  

^a Merlin Park University Hospital   (Ireland)

Author keywords

Adverse events; Anaphylaxis; Contrast media; Contrast induced nephropathy (CIN); Risk factors; Serum creatinine

Indexed keywords

DEHYDRATION; DISEASE CONTROL; HEALTH RISKS; PATIENT MONITORING; PROTEINS; SCREENING;

ADVERSE EVENTS; HYPERTHYROIDISM; NEPHROPATHY; RADIOCONTRAST AGENTS;

TOMOGRAPHY;

CONTRAST MEDIUM;

ANAMNESIS; ANAPHYLAXIS; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DEHYDRATION; HIGH RISK POPULATION; HUMAN; NEPHROTOXICITY; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; THYROTOXICOSIS;

EID: 34248512416     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.02.019     Document Type: Article

References (56)

1. Waybill M.M., and Waybill P.N. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 12 (2001) 3-9
2. Berg K.J. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 34 (2000) 317-322
3. Toms A.P., Cash C.J., Linton S.J., and Dixon A.K. Requests for body computed tomography: increasing workload, increasing indications and increasing age. Eur Radiol 11 (2001) 2633-2637
4. Liistro F., Falsini G., and Bolognese L. The clinical burden of contrast media-induced nephropathy. Ital Heart J 4 (2003) 668-676
5. Kalra M.K., Maher M.M., D'Souza R., and Saini S. Multidetector computed tomography technology: current status and emerging developments. J Comput Assist Tomogr 28 Suppl 1 (2004) S2-S6
6. Thomsen H.S., and Morcos S.K. Management of acute adverse reactions to contrast media. Eur Radiol 14 (2004) 476-481
7. Morcos S.K., Thomsen H.S., and Webb J.A. Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol 11 (2001) 1720-1728
8. American College of Radiology. Manual on contrast media. Version 5.0 ed. (2004), American College of Radiology, Reston, Virginia
9. Katayama H., Yamaguchi K., Kozuka T., Takashima T., Seez P., and Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175 (1990) 621-628
10. Bettmann M.A., Heeren T., Greenfield A., and Goudey C. Adverse events with radiographic contrast agents: results of the SCVIR contrast agent registry. Radiology 203 (1997) 611-620
11. Rich M.W., and Crecelius C.A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 150 (1990) 1237-1242
12. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44 (2004) 1393-1399
13. Konen E., Konen O., Katz M., Levy Y., Rozenman J., and Hertz M. Are referring clinicians aware of patients at risk from intravenous injection of iodinated contrast media?. Clin Radiol 57 (2002) 132-135
14. Lang D.M., Alpern M.B., Visintainer P.F., and Smith S.T. Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med 153 (1993) 2033-2040
15. Vogl T.J., Honold E., Wolf M., Mohajeri H., and Hammerstingl R. Safety of iobitridol in the general population and at-risk patients. Eur Radiol 16 (2006) 1288-1297
16. Cavusoglu E., Chhabra S., Marmur J.D., Kini A., and Sharma S.K. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Minerva Cardioangiol 52 (2004) 419-432
17. Thomsen H.S. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol 181 (2003) 1463-1471
18. Namasivayam S., Kalra M.K., Torres W.E., and Small W.C. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 12 (2006) 210-215
19. Thomsen H.S., and Morcos S.K. ESUR guidelines on contrast media. Abdom Imaging 31 (2006) 131-140
20. van der Molen A.J., Thomsen H.S., and Morcos S.K. Effect of iodinated contrast media on thyroid function in adults. Eur Radiol 14 (2004) 902-907
21. Lang D.M., Alpern M.B., Visintainer P.F., and Smith S.T. Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann Intern Med 115 (1991) 270-276
22. Javeed N., Javeed H., Javeed S., Moussa G., Wong P., and Rezai F. Refractory anaphylactoid shock potentiated by beta-blockers. Cathet Cardiovasc Diagn 39 (1996) 383-384
23. Toogood J.H. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol 81 (1988) 1-5
24. Idee J.M., Pines E., Prigent P., and Corot C. Allergy-like reactions to iodinated contrast agents. A critical analysis. Fundam Clin Pharmacol 19 (2005) 263-281
25. Stang M., Wysowski D.K., and Butler-Jones D. Incidence of lactic acidosis in metformin users. Diab Care 22 (1999) 925-927
26. Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2002:CD002967.
27. Thomsen H.S., and Morcos S.K. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee. Eur Radiol 9 (1999) 738-740
28. Morcos S.K., and Thomsen H.S. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging 28 (2003) 187-190
29. McCarthy C.S., and Becker J.A. Multiple myeloma and contrast media. Radiology 183 (1992) 519-521
30. Morcos S.K. Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 71 (1998) 357-365
31. Gleeson T., O'Dwyer J., Bulugahapitiya S., and Foley D. Contrast-induced nephropathy. Br J Cardiol (Acute Interv Cardiol) 11 (2004) AIC 53-AIC 61
32. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43:S1-290.
33. Alamartine E., Phayphet M., Thibaudin D., Barral F.G., and Veyret C. Contrast medium-induced acute renal failure and cholesterol embolism after radiological procedures: incidence, risk factors, and compliance with recommendations. Eur J Intern Med 14 (2003) 426-431
34. Murphy S.W., Barrett B.J., and Parfrey P.S. Contrast nephropathy. J Am Soc Nephrol 11 (2000) 177-182
35. Morcos S.K., Thomsen H.S., and Exley C.M. Contrast media: interactions with other drugs and clinical tests. Eur Radiol 15 (2005) 1463-1468
36. Palmer F.J. The RACR survey of intravenous contrast media reactions. Final report. Australas Radiol 32 (1988) 426-428
37. Barrett B.J., Parfrey P.S., Vavasour H.M., O'Dea F., Kent G., and Stone E. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 326 (1992) 431-436
38. Steinberg E.P., Moore R.D., Powe N.R., et al. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med 326 (1992) 425-430
39. Morcos S.K. Prevention of contrast media nephrotoxicity-the story so far. Clin Radiol 59 (2004) 381-389
40. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
41. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
42. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
43. Morcos S.K., Thomsen H.S., and Webb J.A. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9 (1999) 1602-1613
44. Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., and Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 (2000) 180-184
45. Teruel J.L., Marcen R., Onaindia J.M., Serrano A., Quereda C., and Ortuno J. Renal function impairment caused by intravenous urography. A prospective study. Arch Intern Med 141 (1981) 1271-1274
46. Parfrey P.S., Griffiths S.M., Barrett B.J., et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320 (1989) 143-149
47. Lee J.K., Warshauer D.M., Bush Jr. W.H., McClennan B.L., and Choyke P.L. Determination of serum creatinine level before intravenous administration of iodinated contrast medium. A survey. Invest Radiol 30 (1995) 700-705
48. Choyke P.L., Cady J., DePollar S.L., and Austin H. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?. Tech Urol 4 (1998) 65-69
49. Myers G.L., Miller W.G., Coresh J., et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 52 (2006) 5-18
50. Levey A., Green T., Kusek J., Beck G., and MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A Abstract A0828
51. Bartholomew B.A., Harjai K.J., Dukkipati S., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004) 1515-1519
52. McCullough P.A., and Sandberg K.R. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med 4 Suppl 5 (2003) S3-S9
53. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
54. Dangas G., Iakovou I., Nikolsky E., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13-19
55. Gault M.H., Longerich L.L., Harnett J.D., and Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron 62 (1992) 249-256
56. McCullough P.A. Beyond serum creatinine: defining the patient with renal insufficiency and why?. Rev Cardiovasc Med 4 Suppl 1 (2003) S2-S6